Literature DB >> 18631768

The epidemiology of progressive supranuclear palsy.

Lawrence I Golbe1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18631768     DOI： 10.1016/S0072-9752(07)01242-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  6 in total

1.  A geographical cluster of progressive supranuclear palsy in northern France.

Authors:  Dominique Caparros-Lefebvre; Lawrence I Golbe; Vincent Deramecourt; Claude-Alain Maurage; Vincent Huin; Valerie Buée-Scherrer; Helene Obriot; Bernard Sablonnière; Francois Caparros; Luc Buée; Andrew J Lees
Journal:  Neurology       Date:  2015-09-09       Impact factor: 9.910

2.  Rare diseases: matching wheelchair users with rare metabolic, neuromuscular or neurological disorders to electric powered indoor/outdoor wheelchairs (EPIOCs).

Authors:  Lorraine H De Souza; Andrew O Frank
Journal:  Disabil Rehabil       Date:  2015-12-30       Impact factor: 3.033

3.  Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.

Authors:  Rebecca R Valentino; Nikoleta Tamvaka; Michael G Heckman; Patrick W Johnson; Alexandra I Soto-Beasley; Ronald L Walton; Shunsuke Koga; Ryan J Uitti; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross
Journal:  Acta Neuropathol Commun       Date:  2020-09-17       Impact factor: 7.801

Review 4.  Frontrunner in Translation: Progressive Supranuclear Palsy.

Authors:  Ali Shoeibi; Nahid Olfati; Irene Litvan
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

5.  Prevalence and Cost of Care for Parkinson's Disease in Luxembourg: An Analysis of National Healthcare Insurance Data.

Authors:  Susanne Schmitz; Michel Vaillant; Christell Renoux; Robert L Konsbruck; Pierre Hertz; Magali Perquin; Lukas Pavelka; Rejko Krüger; Laetitia Huiart
Journal:  Pharmacoecon Open       Date:  2022-01-16

Review 6.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.